Glial modulation of retinal ganglion cell death in glaucoma

Journal of Glaucoma

Volumn 12, Issue 1, 2003, Pages 63-68

  Tezel, Gülgün ^a   Wax, Martin B ^b,c  

^a University of Louisville School of Medicine   (United States)

^b PFIZER INC   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTE; CELL DEATH; CELL FUNCTION; CELL PROTECTION; CELL TYPE; DISEASE ASSOCIATION; GLAUCOMA; GLIA CELL; HUMAN; NERVE CELL; NERVOUS SYSTEM; NEUROPROTECTION; OPTIC NERVE; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW;

CELL DEATH; GLAUCOMA; HUMANS; NEUROGLIA; OPTIC DISK; RETINAL GANGLION CELLS;

EID: 0037329386     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200302000-00014     Document Type: Review

References (68)

1. Ridet JL, Malhotra SK, Privat A, et al. Reactive astrocytes: cellular and molecular cues to biologic function [published erratum appears in Trends Neurosci 1998;21:80]. Trends Neurosci 1997;12:570-577.
2. Perez SE, Steller H. Migration of glial cells into retinal axon target field in Drosophila melanogaster. J Neurobiol 1996;3:359-373.
3. Hatten ME, Liem RK, Shelanski ML, et al. Astroglia in CNS injury. Glia 1991;2:233-243.
4. Eddleston M, Mucke L. Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience. 1993;1:15-36.
5. Norenberg MD. Astrocyte responses to CNS injury. J Neuropathol Exp Neurol 1994;3:213-220.
6. Lieberman AP, Pitha PM, Shin HS, et al. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A 1989;16:6348-6352.
7. Dugan LL, Sensi SL, Canzoniero LM, et al. Mitochondrial production of reactive oxygen species in cortical neurons after exposure to N-methyl-D-aspartate. J Neurosci 1995;10:6377-6388.
8. Mite L, Cassatella MA, Szendrei GI, et al. Activation of microglial cells by beta-amyloid protein and interferon- gamma. Nature 1995;6523:647-650.
9. Cotinet A, Goureau O, Hicks D, et al. Tumor necrosis factor and nitric oxide production by retinal Muller glial cells from rats exhibiting inherited retinal dystrophy. Glia 1997;1:59-69.
10. de Kozak Y, Cotinet A, Goureau O, et al. Tumor necrosis factor and nitric oxide production by resident retinal glial cells from rats presenting hereditary retinal degeneration. Ocul Immunol Inflamm 1997;2:85-94.
11. Viviani B, Corsini E, Galli CL, et al. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 1998;2:271-276.
12. Raivich G, Bohatschek M, Kloss CU, et al. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 1999;1:77-105.
13. Ye H, Hernandez MR. Heterogeneity of astrocytes in human optic nerve head. J Comp Neurol 1995;4:441-452.
14. Neufeld AH. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch Ophthalmol 1999;8:1050-1056.
15. Hollander H, Makarov F, Dreher Z, et al. Structure of the macroglia of the retina: sharing and division of labor between astrocytes and Muller cells. J Comp Neurol 1991;4:587-603.
16. Provis JM, Penfold PL, Edwards AJ, et al. Human retinal microglia: expression of immune markers and relationship to the glia limitans. Glia 1995;4:243-256.
17. Hernandez MR, Pena JD. The optic nerve head in glaucomatous optic neuropathy. Arch Ophthalmol 1997;3:389-395.
18. Wang L, Cioffi GA, Cull G, et al. Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest Ophthalmol Vis Sci 2002;4:1088-1094.
19. Reichelt W, Pannicke T, Biedermann B, et al. Comparison between functional characteristics of healthy and pathologic human retinal Muller glial cells. Surv Ophthalmol 1997;S105-117.
20. Harada T, Harada C, Watanabe M, et al. Functions of the two glutamate transporters GLAST and GLT-1 in the retina. Proc Natl Acad Sci U S A 1998;8:4663-4666.
21. Rauen T. Diversity of glutamate transporter expression and function in the mammalian retina. Amino Acids 2000;1:53-62.
22. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000;1:1-14.
23. Dreyer EB, Zurakowski D, Schumer RA, et al. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996;3:299-305.
24. Vorwerk CK, Naskar R, Schuettauf F, et al. Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death. Invest Ophthalmol Vis Sci 2000;11:3615-3621.
25. Levkovitch-Verbin H, Martin KR, Quigley HA, et al. Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection. J Glaucoma 2002;11:396-405.
26. Martin KR, Levkovitch-Verbin H, Valenta D, et al. Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci 2002;7:2236-2243.
27. Hernandez MR, Andrzejewska WM, Neufeld AH. Changes in the extracellular matrix of the human optic nerve head in primary open-angle glaucoma. Am J Ophthalmol 1990;2:180-188.
28. Morrison JC, Dorman-Pease ME, Dunkelberger GR, et al. Optic nerve head extracellular matrix in primary optic atrophy and experimental glaucoma. Arch Ophthalmol 1990;7:1020-1024.
29. Quigley HA, Dorman-Pease ME, Brown AE. Quantitative study of collagen and elastin of the optic nerve head and sclera in human and experimental monkey glaucoma. Curr Eye Res 1991;9:877-888.
30. Hernandez MR. Ultrastructural immunocytochemical analysis of elastin in the human lamina cribrosa. Changes in elastic fibers in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 1992;10:2891-2903.
31. Varela HJ, Hernandez MR. Astrocyte responses in human optic nerve head with primary open-angle glaucoma. J Glaucoma 1997; 5:303-313.
32. Yan X, Tezel G, Wax MB, et al. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch Ophthalmol 2000;5:666-673.
33. Agapova OA, Ricard CS, Salvador-Silva M, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 2001;3:205-216.
34. Minckler DS, Spaeth GL. Optic nerve damage in glaucoma. Surv Ophthalmol 1981;3:128-148.
35. Quigley HA, Hohman RM, Addicks EM, et al. Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma. Am J Ophthalmol 1983;5:673-691.
36. Yang JL, Neufeld AH, Zorn MB, et al. Collagen type I mRNA levels in cultured human lamina cribrosa cells: effects of elevated hydrostatic pressure. Exp Eye Res 1993;5:567-574.
37. Kobayashi S, Vidal I, Pena JD, et al. Expression of neural cell adhesion molecule (NCAM) characterizes a subpopulation of type 1 astrocytes in human optic nerve head. Glia 1997;3:262-273.
38. Wax MB, Tezel G, Kobayashi S, et al. Responses of different cell lines from ocular tissues to elevated hydrostatic pressure. Br J Ophthalmol 2000;4:423-428.
39. Ricard CS, Kobayashi S, Pena JD, et al. Selective expression of neural cell adhesion molecule (NCAM)-180 in optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro. Brain Res Mol Brain Res 2000;1-2:62-79.
40. Hernandez MR, Pena JDO, Selvidge JA, et al. Hydrostatic pressure stimulates synthesis of elastin in cultured optic nerve head astrocytes. Glia 2000;33:122-136.
41. Yang J, Yang P, Tezel G, Patil RV, et al. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. Invest Ophthalmol Vis Sci 2001;2:365-371.
42. Wax MB, Tezel G, Edward PD. Clinical and ocular histopathologic findings in a patient with normal-pressure glaucoma [see comments]. Arch Ophthalmol 1998;8:993-1001.
43. Hernandez MR. The optic nerve head in glaucoma: role of astrocytes in tissue remodeling. Prog Retin Eye Res 2000;3:297-321.
44. Schnabel J. Glaucomatose sehnervenleiden. Arch Augenheilkd. 1892;273-292.
45. Zimmerman ZLE, De Venecia G, Hamasaki DI. Pathology of the optic nerve in experimental acute glaucoma. Invest Ophthalmol 1967;2:109-125.
46. Kalvin NH, Hamasaki DI, Gass JD. Experimental glaucoma in monkeys. I. Relationship between intraocular pressure and cupping of the optic disc and cavernous atrophy of the optic nerve. Arch Ophthalmol 1966;1:82-93.
47. Lampert PW, Vogel MH, Zimmerman LE. Pathology of the optic nerve in experimental acute glaucoma. Electron microscopic studies. Invest Ophthalmol 1968;2:199-213.
48. Tezel G, Hernandez MR, Wax MB. In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head. Glia 2001;3:178-189.
49. Neufeld AH, Hernandez MR, Gonzalez M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol 1997; 4:497-503.
50. Yuan L, Neufeld AH. Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head [In Process Citation]. Glia 2000;1:42-50.
51. Tezel G, Wax MB. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J Neurosci 2000;23:8693-8700.
52. Shafer RA, Murphy S. Activated astrocytes induce nitric oxide synthase-2 in cerebral endothelium via tumor necrosis factor alpha. Glia 1997;4:370-379.
53. Goureau O, Amiot F, Dautry F, et al. Control of nitric oxide production by endogenous TNF-alpha in mouse retinal pigmented epithelial and Muller glial cells. Biochem Biophys Res Commun. 1997;1:132-135.
54. Heneka MT, Loschmann PA, Gleichmann M, et al. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem. 1998;1:88-94.
55. Liu B, Neufeld AH. Nitric oxide synthase-2 in human optic nerve head astrocytes induced by elevated pressure in vitro. Arch Ophthahnol 2001;2:240-245.
56. Neufeld AH, Sawada A, Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A. 1999;17:9944-9948.
57. Tezel G, Li LY, Patil RV, Wax MB. Tumor necrosis factor-alpha and its receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci 2001;42:1787-1794.
58. Gottschall PE, Yu X. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes. J Neurochem. 1995;4:1513-1520.
59. Migita K, Eguchi K, Kawabe Y, et al. TNF-alpha-mediated expression of membrane-type matrix metalloproteinase in rheumatoid synovial fibroblasts. Immunology. 1996;4:553-557.
60. Bond M, Fabunmi RP, Baker AH, et al. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 1998;1:29-34.
61. Rezaie T, Child A, Hitchings R, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002; 5557:1077-1079.
62. Gregerson DS. Immune privilege in the retina. Ocul Immunol Inflamm. 1998;4:257-267.
63. Becher B, Prat A, Antel JP. Brain-immune connection: immunoregulatory properties of CNS-resident cells. Glia 2000;4:293-304.
64. Kim SU. Antigen expression by glial cells grown in culture. J Neuroimmunol 1985;4-6:255-282.
65. Yong VW, Yong FP, Ruijs TC, et al. Expression and modulation of HLA-DR on cultured human adult astrocytes. J Neuropathol Exp Neurol 1991;1:16-28.
66. Yuan L, Neufeld AH. Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 2001;5:523-532.
67. Wax MB, Barrett DA, Pestronk A. Increased incidence of paraproteinemia and autoantibodies in patients with normal-pressure glaucoma. Am J Ophthalmol 1994;5:561-568.
68. Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol 1999;7:917-924.